QUECTEL-WIRELESS
Quectel Wireless Solutions, a global IoT solutions provider, is pleased to be showcasing some its industry leading IoT connectivity solutions and technologies, catering to various industries and applications at Embedded World 2024 in Nürnberg.
During the event, visitors can explore Quectel’s extensive portfolio of IoT modules and solutions designed to meet the diverse needs of the IoT ecosystem. From 5G and LTE-M/NB-IoT modules to GNSS positioning modules, Quectel offers a comprehensive range of products that empower businesses to build reliable, scalable, and future-proof IoT solutions.
In addition, Zeljko Maric, Product Development Manager at Quectel, will be participating in a panel session centered on IoT Modem Reference Design or IoT SoC Modules Modem for Embedded Designers. The session is scheduled to take place in the exhibitor forum, Hall 3, on Wednesday, April 10th, at 3:30 PM.
"We are excited to participate in Embedded World 2024 and showcase our latest innovations in IoT connectivity," said Norbert Muhrer, President and CSO, Quectel Wireless Solutions. "As a leading provider of IoT modules, Quectel is dedicated to empowering businesses worldwide with reliable, secure and innovative connectivity solutions. We look forward to engaging with industry peers, customers, and partners at the event."
Quectel is also highlighting some of its customers’ innovations during the show:
- Broadcast Sports International: 5G MT-UHD, an advanced 5G-enabled broadcasting tool that opens new horizons for live sports and events coverage.
- Consenz Head-up Display – equipped with the Quectel SC680A module, this cost-effective retrofit Head-Up Display (HUD) solution from Consenz enhances driving safety.
- Speed Tech Corporation /Luxshare-ict Precision 5G MiFi unit alongside their 5G Indoor CPE and 5G Outdoor CPE units.
- Microamp Solutions’ CellBox Air 5G mmWave Radio Unit is a system that connects to the Distributed Unit (DU) through the O-RAN 7.2x interface and features an integrated Massive MIMO antenna array.
- MikroTik’s Chateau 5G Router is a device that epitomizes the fusion of sophisticated design and powerful 5G connectivity, designed to cater to the growing demand for faster and more reliable home and office internet solutions.
- Monitair MonAir-CO2, a unique environmental sensor is equipped with the advanced Quectel EG915U LTE Cat1bis module and YC0002AA antenna, making it a one-of-a-kind 4G battery-operated device capable of meticulously tracking CO2, temperature, humidity, COV, NOX, and noise levels.
- Particle's M-SoM M404 M.2 system-on-module embeds multi-radio connectivity in IoT devices features LTE-M + 2G fallback + dual-band Wi-Fi and includes a high-end modern microcontroller with Arm TrustZone, secure boot, and capable of running Edge ML models, combined with a best-in-class Quectel connectivity module.
- PayEye eyePOS 3 - The world's only terminal to support iris and facial biometrics fusion and all types of cashless payments - card, contactless (NFC) and mobile, featuring the QUECTEL SC668S-EM.
- Sixfab will be showcasing a number of devices on the Quectel stand including the Jumpstart 5G, a fully certified, all-inclusive, ready-to-connect IoT computer for high-speed applications, a 4G/LTE Cellular Modem Kit for Raspberry Pi, a versatile 4G/LTE connectivity solution for Raspberry Pi and the Pico LTE, a comprehensive platform for global cellular connectivity & low-power IoT, pre-integrated with AWS IoT, Azure IoT & more.
- Ricon will be presenting the S9980DSL-LTEv2 High-Speed Fiber Optical xDSL Fixed/Wireless Router with Integrated 4.5G Cellular Interface and S9955OUT-5G Industrial Outdoor Router
- Roltek will be demonstrating their Edge Pro LTE8421 4G IOT Gateway, designed using the Quectel EG915 module to provide seamless and reliable connectivity even in challenging conditions
- ZCS Lawn Mower Robot: The ZCS autonomous lawn mower robot, powered by the Quectel LG69T Series module, an automotive grade dual-band multi-constellation GNSS module integrating DR/RTK, demonstrates the future of smart, connected landscaping.
As part of the Quectel stand, Ikotek, a leading IoT original design manufacturer (ODM), will be there to showcase its capabilities in IoT device design, manufacturing and certification delivering high quality products and services to reduce complexity, speed up time to market, eliminate risk and reduce costs.
Finally, Acceleronix, a global IoT solutions and services enablement provider primarily focused on serving OEMs and enterprises, will have a presence on the Quectel stand. Delivering edge-device management software, Connectivity-as-a-Service, specialized vertical software, and mobile applications, Acceleronix offers comprehensive solutions tailored to empower every facet of IoT product lifecycle, spanning from development to data management and visualization.
Attendees to Embedded World can find Quectel on stand 3-318.
About Quectel
Quectel’s passion for a smarter world drives us to accelerate IoT innovation. A highly customer-centric organization, we are a global IoT solutions provider backed by outstanding support and services. Our growing global team of 5,900 professionals sets the pace for innovation in cellular, GNSS, Wi-Fi and Bluetooth modules as well as antennas and services.
With regional offices and support across the globe, our international leadership is devoted to advancing IoT and helping build a smarter world.
For more information, please visit: www.quectel.com, LinkedIn, Facebook, and X.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240408354948/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
CoMotion GLOBAL 2025 Launches in Riyadh: Global Mobility Leaders Unite in Saudi Capital to Chart Urban Future7.12.2025 13:00:00 CET | Press release
Summit debuts Mayors in Motion initiative and CoMotion Urban Visionary Distinction as Riyadh showcases its rise as global mobility testbed Riyadh is rapidly becoming one of the world's most ambitious urban mobility laboratories, where next-generation technologies move from blueprint to real-world deployment on city streets at unprecedented scale. CoMotion GLOBAL 2025, the world's most influential gathering of urban mobility leaders, opens today in Riyadh for a three-day summit bringing together innovators from Africa, Asia, Europe, the Americas, and the Middle East. Running December 7-9, the event will explore how electrification, autonomy, AI-enabled transport, and giga-project urbanism are reshaping cities worldwide. The summit will spotlight everything from high-performance EVs and breakthrough autonomous fleets to emerging-market transport solutions and new mobility models, demonstrating how the Kingdom is opening new pathways for global mobility leadership. Strategic Partnerships
Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting6.12.2025 15:30:00 CET | Press release
Results from Phase 2a IMPRSSION study demonstrate sapablursen significantly reduced phlebotomy rate, controlled hematocrit and increased serum hepcidin Sapablursen was generally safe and well tolerated Results support further development of sapablursen in a Phase 3 study Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which On
Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera6.12.2025 15:30:00 CET | Press release
52-Week Results from the Phase 3 VERIFY Study of Rusfertide Demonstrated Sustained Hematocrit Control and Response, Defined by Absence of Phlebotomy Eligibility, with No New Safety SignalsThese Data Build on Positive 32-Week Primary Analysis from VERIFY, Which Met its Primary Efficacy Endpoint and All Four Key Secondary EndpointsPatients Crossing Over from Placebo to Rusfertide at 32 Weeks Achieved a Similar Response Rate to Those Initially Randomized to Rusfertide, with 77.9% Achieving Absence of Phlebotomy Eligibility Between Weeks 40-52Four-Year Results from the Combined REVIVE and Long-Term Extension THRIVE Study Demonstrated a 13-Fold Reduction in Annual Rate of Phlebotomies from Baseline Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) announce that new 52-week results from the pivotal Phase 3 VERIFY study evaluating rusfertide in patients with polycythemia vera (PV) will be presented in an oral presentation at the 67th American Society
Vertex Presents New Data on CASGEVY®, Including First-Ever Data in Children Ages 5-11 Years, at the American Society of Hematology Annual Meeting and Announces Plan for Global Regulatory Submissions6.12.2025 13:01:00 CET | Press release
- Data from pivotal studies of CASGEVY in children ages 5-11 years with severe sickle cell disease or transfusion-dependent beta thalassemia demonstrates the transformative potential of the therapy in younger patients -- Efficacy and safety data in children 5-11 years are consistent with the durable and positive benefit/risk profile established from clinical studies in patients 12 years of age and older -- Vertex expects to initiate global regulatory submissions for CASGEVY in children 5-11 years in 1H 2026 - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data from multiple studies demonstrating the clinical benefits of CASGEVY® (exagamglogene autotemcel) in people ages 5 years and older living with severe sickle cell disease (SCD) or transfusion-dependent beta thalassemia (TDT). The results, including the first presentation of clinical data from pivotal studies in children ages 5-11 years, and longer-term data from the pivotal studies of people with severe SCD and
Leading Global Scientists Gather at Tengchong Scientists Forum to Explore Innovative Pathways in Frontier Technologies6.12.2025 12:31:00 CET | Press release
The 2025 Tengchong Scientists Forum opened on Saturday in southwest China’s Yunnan Province, convening leading scientists and academic figures to examine innovation across frontier fields including artificial intelligence, biodiversity and quantum technology. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251205499197/en/ Opening ceremony of Tengchong Scientists Forum on 6th December, 2025 Notable participants include Nobel Physics laureate Konstantin Novoselov, Fields Medalist Efim Zelmanov and Turing Award winner Andrew Chi-Chih Yao, who join 127 academicians, 77 university presidents from China and abroad, over 400 scholars and more than 600 entrepreneurs and financiers. The gathering aims to deepen collaboration between cutting-edge research and industrial development. Under the theme “Science · AI changing the World,” the forum features ten sub-forums, academic sessions and thematic events supporting major cooperation p
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom